B

Beam Therapeutics

Develops base editing–based precision medicines

Director – Regulatory CMC

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeCambridge, MA, USA$210k - $260k

About the Job

Requirements

  • A Bachelor of Science degree in a scientific or engineering discipline.
  • Typically 12+ years in the biotech industry, including 9+ years of Regulatory CMC experience, or related experience in manufacturing, analytical, or quality assurance with direct technical writing experience for IND/CTA/MF and BLA/MAA submissions.
  • Comprehensive knowledge of FDA, EMA, and ICH guidelines, with the ability to articulate and apply these principles to Regulatory CMC strategies for novel products.
  • Strong experience with CTD format and content for regulatory filings.
  • Excellent organizational, written and oral communication, and time management skills; ability to communicate complex issues succinctly and logically; and strong listening skills.
  • Experience with related CMC disciplines, such as manufacturing, analytical, or quality assurance, and the ability to take creative and imaginative approaches to new and diverse problem solving.
  • Ability to generate innovative solutions to complex regulatory problems, communicate effectively with key stakeholders, and respond flexibly to changing priorities or unexpected events.

Responsibilities

  • Provide regulatory CMC strategic leadership within Regulatory and on cross-functional teams to support development of innovative genomic medicines and ex-vivo and in-vivo therapies.
  • Develop and proactively communicate regulatory CMC strategies, risks, and key issues in an evolving regulatory landscape.
  • Act as the regulatory CMC lead and department representative in matrix teams for development programs.
  • Support development of manufacturing, analytical, and supply chain strategies and provide expert regulatory guidance to enable global implementation.
  • Define CMC data and documentation requirements for quality sections of regulatory dossiers, including IND/CTA/MF and BLA/MAA submissions.
  • Plan and manage preparation of high-quality CMC-related global regulatory submission elements, including authoring and critical review, ensuring regulatory compliance, scientific excellence, accuracy, source information traceability, and consistency with related filings and program timelines.
  • Critically review detailed scientific information in CMC documents and assess whether technical arguments are clear and conclusions are adequately supported by data.
  • Evaluate CMC-related change proposals for regulatory impact and filing requirements, and provide strategic guidance for optimal implementation of changes.
  • Develop regulatory processes and procedures to support CMC components of regulatory submissions.
  • Support creation and maintenance of CMC submission templates and dossier standards.
  • Lead and support global health authority interactions for CMC-related topics, including defining strategy, preparation, and meeting facilitation.
  • Support Quality Assurance in preparing for and hosting GMP and pre-approval inspections.
  • Develop and maintain collaborative partnerships with key internal and external stakeholders.
  • Participate in regulatory intelligence activities; monitor regulatory guidelines and trends related to global CMC regulations and guidance; advise CMC and project teams on applicability and impact to internal programs; and anticipate and communicate potential regulatory paradigm shifts.

Desired Qualifications

  • Experience with cell and gene therapy and/or lipid nanoparticles.
  • Diverse experience including biologics in the cell therapy space, drugs, and international filings.

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs